Full Text View
Tabular View
No Study Results Posted
Related Studies
Anti-MAG First Administration to Human
This study has been completed.
Study NCT00622609   Information provided by GlaxoSmithKline

First Received on February 13, 2008.   Last Updated on March 15, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cerebrovascular Accident
Additional conditions recognized in this trial
Cerebral Infarction
Chronic Disease
Stroke
More general conditions related to this trial
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Disease Attributes
Nervous System Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
GSK249320
Placebo
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services